H ow the innate immune system initially recognizes the replicating influenza virus is an important determinant of the infection outcome 1 . However, there is limited knowledge about these early immune defence mechanisms and how they affect disease progression. The host immune system first encounters influenza virus in the upper airways to which initial virus replication is restricted 2 . Later, infection progresses to the lower respiratory tract through the airway epithelium of the trachea; this is essential for the development of the acute phase of the disease 3 . Most of the knowledge about the immune response in the trachea has been gained from studies focusing on the pulmonary phase of the infection 2 ; therefore, there is a need for better characterization of the early response in the trachea.
The immune response to airborne pathogens involves their recognition by macrophages and dendritic cells (DCs) located underneath the mucosal cell layer 4 . Tracheal DCs have been divided into subtypes according to their anatomical location and expression of surface markers 4, 5 . One of the best-studied subtypes is the resident conventional DCs (cDCs) that have an important role in initiating the adaptive response by migrating to regional lymph nodes (LNs) and presenting antigen to T cells 6 . A second group of DCs, the inflammatory DCs (IDCs), perform their function at the site of infection 7 . IDCs are an important source of cytokines such as tumour-necrosis factor (TNF) and inflammatory molecules such as nitric oxide 8 . However, the precise functions of IDCs during influenza infection have not been identified.
The activation of these cells is associated with the detection of viral components by pattern-recognition receptors commonly expressed by DCs 9 . C-type lectin receptors are pattern-recognition receptors that bind specific pathogen-associated carbohydrate structures 10 . The C-type lectin receptor DC-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN) murine homologue SIGN-R1 is known to directly recognize bacterial 11 , viral 12 and fungal 13 pathogens. Previous studies have described the presence of cells expressing SIGN-R1 in the skin, lungs and in secondary lymphoid organs such as the spleen 14 and LNs 12 . However, the specific function of this receptor in the response against infectious virus is not known.
Here, we show that IDCs are recruited into the tracheal epithelium and recognize influenza virus via SIGN-R1. The production of inflammatory chemokines by these cells induces the recruitment of natural killer (NK) cells, which is essential for the control of viral replication in the trachea. different subsets of DCs and RTMs before and after influenza infection, we stained explants from tracheas of CD11c-YFP mice with antibodies against CD11b and Ly6C ( Fig. 2b and Supplementary  Fig. 2a ). Consistent with the flow cytometry data, we could not detect any IDCs in uninfected animals ( Supplementary Fig. 2b ). In the infected mice, we found that recruited IDCs were located towards the lumen of the trachea, unlike the other cell types, which were mainly located in the lamina propria ( Fig. 2c ).
Type I interferon-dependent CCL2 production recruits IDC precursors to the trachea. To characterize the antiviral response that leads to the recruitment of IDCs, we assessed the expression of type I interferon (IFN) in the trachea. We observed a significant upregulation of the transcript levels of both Ifna and Ifnb during the first 2 d.p.i. (Fig. 3a) . Moreover, cytoplex analysis confirmed that protein levels of IFN-β were significantly elevated in both WT and CCR2-KO mice at 3 d.p.i. (Fig. 3b ). We also detected a significant increase in levels of RNA encoding the chemokine CCL2-a CCR2 ligand-during the first 3 d.p.i. (Fig. 3c) , coinciding with an increase in CCL2 protein (Fig. 3d ). RTMs, together with pDCs and IDCs, were the main producers of CCL2 ( Supplementary Fig. 3a, b) . Interestingly, we observed a similar pattern of expression for CCL2 and type I IFN during the first 7 d.p.i. ( Supplementary Fig. 3c ), concurrent with IDC recruitment to the trachea. To examine whether the expression of the two cytokines is linked, we analysed CCL2 protein levels in mice deficient in the type I IFN receptor (IFNAR). This analysis showed that signalling through IFNAR was required for secretion of CCL2 (Fig. 3d ). In addition, we observed a 
Fig. 1 | Influenza infection promotes early recruitment of IDCs to the trachea. a, Flow cytometric characterization of IDCs (CD45
+ MHCII + CD11c + CD11b + Ly6C high ), pDCs (CD45 + MHCII + CD11c Int B220 + CD11b − Bst2 + Ly6C + ), CD103 + cDCs (CD45 + MHCII + CD11c + CD11b − Ly6C − CD103 + ), CD11b + cDCs (CD45 + MH CII + CD11c + CD11b + Ly6C − CD103 − ) and resident RTMs (CD45 + MHCII + CD11c − B220 − Ly6C − CD11b + F4/80 + ) in mouse trachea. b,
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NATuRe MICRobIoLoGy marked decrease in the numbers of CCR2 + monocytes in tracheas from IFNAR-KO mice at 3 d.p.i. (Fig. 3e ) and a similar reduction in the number of IDCs (Fig. 3f ), consistent with the role of CCR2 + monocytes as IDC precursors.
IDCs express the lectin receptor SIGN-R1 that recognizes glycosylated influenza viral proteins.
We assessed the expression of SIGN-R1 in the mononuclear phagocytic cell compartment of the trachea using flow cytometric analysis. We found that SIGN-R1 was highly expressed by IDCs at 3 d.p.i. (Fig. 4a,b ). Moreover, 3D confocal microscopy revealed that SIGN-R1 colocalized with DiOlabelled influenza virus after 1 h of incubation ( Fig. 4c ), suggesting that this C-type lectin, expressed in IDCs, is able to bind influenza virus. To examine this possibility, we performed enzyme-linked immunosorbent assay (ELISA), which confirmed that SIGN-R1 binds with high affinity to whole influenza virus (with half-maximal effective concentration, EC 50 = 1.67 μg ml −1 ; Supplementary Fig. 4a ). To further investigate this interaction, we performed surface plasmon resonance (SPR) assays, which showed that SIGN-R1 binds the haemagglutinin (HA) glycoprotein of influenza PR8 virus with an equilibrium dissociation constant (K D ) of 142 nM (Fig. 4d, top) . Next, to evaluate whether the binding of influenza virus to SIGN-R1 could be abrogated by interfering with glycosylation, we removed glycan moieties from HA using different glycosidases. We used endoglycosidase H to eliminate mannose glycosylation from HA. However, since all later oligosaccharide structures are resistant to endoglycosidase H, we also used peptide-N-glycosidase F (PNGase F), which cleaves between the innermost showing the 3D reconstruction of the DC subsets and RTMs located in the tracheal mucosa at 3 d.p.i. Cells were characterized on the basis of expression of CD11c (green), CD11b (light blue) and Ly6C (red). IDCs, CD11c + CD11b + Ly6C + ; CD103 + cDCs, CD11c + CD11b − Ly6C − ; CD11b + cDCs, CD11c + CD11b + Ly6C − ; RTMs, CD11c − CD11b + Ly6C − . Scale bars, 16 μm (IDC panels); 20 μm (other panels). c, Left: representative 3D reconstruction from confocal micrographs of a trachea at 3 d.p.i. showing the location of IDCs (red), CD103 + cDCs (green), CD11b + cDCs (yellow) and RTMs (light blue) in relation to the basement membrane (violet). Scale bars, 20 μm. Right: box plot representing the position of the cell subtypes in relation to the basement membrane in the tracheal mucosa at 3 d.p.i. Cells located towards the lamina propria were given positive values while cells located towards the luminal side were given negative values (data are based on the analysis of three confocal reconstructions; IDC, n = 61; CD103 + cDC, n = 54; CD11b + cDC, n = 40; RTM, n = 40). Data are representative of at least three independent experiments. In c, boxes show 25th to 75th percentiles, the line represents the median and the whiskers show 5th to 95th percentiles. Data were analysed using the two-tailed Student's t-test.
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N-acetylglucosamine and asparagine residues of high-mannose glycans regardless of the complexity of the glycan. We monitored glycosylation removal by western blotting of the protein after treatment and found that PNGase F was the most efficient enzyme for removal of all N-linked glycans ( Supplementary Fig. 4b ).
After N-linked glycans were removed from HA, we could no longer detect binding with SIGN-R1 ( Fig. 4d , middle). Of note, HA still bound to the monoclonal antibody H36-7 17 following removal of N-linked glycans ( Supplementary Fig. 4c ), indicating that HA remained correctly folded after PNGase F treatment. Next, we performed binding assays with different HA subtypes to investigate the possibility that SIGN-R1 recognizes other flu strains. In agreement with the affinity measurement by SPR, we observed high binding titres (EC 50 value shown) for H1 (PR8 (0.66 μg ml −1 ) and New Caledonia (0.81 μg ml −1 )), H3 (1.19 μg ml −1 ) and H5
(1 μg ml −1 ) strains ( Fig. 4e ). In addition, SIGN-R1 binding was also observed with neuraminidase subtype 1 (N1) (EC 50 = 0.63 μg ml −1 ; Supplementary Fig. 4d ). In this assay, FI6, an antibody specific for the stem region of HA 18 , was included to confirm that the observed binding was not due to HA contamination in the N1 purification. Of note, SIGN-R1 also bound to other respiratory viruses, such as the human respiratory syncytial virus 19 (RSV; EC 50 = 0.98 μg ml −1 ) and the human metapneumovirus 20 (MPV; EC 50 = 1.14 μg ml −1 ) ( Supplementary Fig. 4a ). In sum, these results indicate that SIGN-R1 recognizes several viruses by targeting the carbohydrate moiety of glycoproteins. Moreover, we observed that addition of a SIGN-R1-blocking antibody significantly reduced the binding of DiO-labelled influenza PR8 to SIGN-R1 + IDCs (Fig. 4f ), confirming the role of this receptor in the attachment of the virus on IDCs. H3 (EC 50 = 1.19 µg ml -1 ) H5 (EC 50 = 1.00 µg ml -1 ) 0.001 0.01 0.1 1 10 100 
SIGN-R1 is involved the production of inflammatory chemokines by IDCs and the recruitment of NK cells into the tracheal mucosa.
To investigate the role of IDCs as inducers of the inflammatory response, we studied the production of different chemokines in tracheal lavage from CCR2-KO and SIGN-R1-KO mice at 3 d.p.i. We found that the absence of IDCs or SIGN-R1 resulted in a significant reduction in the levels of the chemokines CCL5, CXCL9 and CXCL10 (Fig. 5a,b and Supplementary Fig. 5a ). Furthermore, the reduced chemokine expression in SIGN-R1-KO mice was not a result of a deficiency in DCs and RTMs relative to WT mice ( Supplementary Fig. 5b ). The specific expression of these chemokines by IDCs and their reduced levels in SIGN-R1-KO mice were confirmed intracellular staining and flow cytometry ( Fig. 5c-f ). To examine whether the observed differences were due to the direct interaction of SIGN-R1 with viral proteins, we isolated IDCs generated by intranasal administration of polyinosinic:polycytidylic acid (Poly I:C); these IDCs exhibited similar SIGN-R1 expression levels to those in tracheal IDCs at 3 d.p.i. ( Supplementary Fig. 5c ). We incubated these IDCs in vitro with a vaccine suspension containing HA. Twelve hours after stimulation, WT IDCs treated with HA showed increased production of CCL5 compared with untreated controls, whereas SIGN-R1-KO IDCs did not ( Supplementary Fig.  5d ). We also confirmed that IDCs were the main source of these chemokines in the trachea at 3 d.p.i. and that SIGN-R1 deficiency reduced chemokine expression levels only in IDCs (Fig. 5g,h and Supplementary Fig. 5e ). To investigate the roles of CCL5, CXCL9 and CXCL10 in the recruitment of NK cells to the infection site 21 , we developed a flow cytometry assay ( Fig. 5i ) to detect the infiltration of NK cells in the trachea (Fig. 5j ). We observed an early peak in the number of NK cells in the infected trachea, which coincided with the peak of IDCs at 3 d.p.i. Moreover, confocal microscopy analysis indicated that the majority of NK cells were positioned towards the luminal side, in close proximity to IDCs (average distance of 66.2 µm; Fig. 5k ,l and Supplementary Fig. 5f ). On average, 25.5% of the NK cells analysed established contacts with IDCs ( Supplementary Fig. 5g ). Furthermore, we observed that NK cells expressed the receptors CCR5 and CXCR3, which bind to the chemokines CCL5, CXCL9 and CXCL10 22 , but not to CCR2 (Fig. 5m ). The recruitment of tracheal NK cells was partly dependent on IDCs, as demonstrated by the reduced number of these cells in CCR2-KO and SIGN-R1-KO mice ( Fig. 5n ).
SIGN-R1 + IDCs are required to control influenza infection.
Next, we investigated the involvement of IDCs in the activation and functional properties of the recruited NK cells. We detected a significant decrease in the number of cells positive for the markers CD69, granzyme B, perforin, NKG2D, NKp46, CD11b and IFN-γ in CCR2-KO and SIGN-R1-KO mice relative to WT mice at 3 d.p.i. (Fig. 6a ). The observed decrease also correlated with a significant decrease in the frequency of NK cells positive for the same markers and the expression levels of CD69, granzyme B, CD11b and IFN-γ, but not of perforin, NKG2D and NKp46, in NK cells from CCR2-KO and SIGN-R1-KO mice ( Fig. 6b and Supplementary  Fig. 6a ). We detected a significant increase in the transcription levels of Il18 in WT mice during the first 3 d.p.i. (Fig. 6c ); the magnitude of this increase was significantly reduced in CCR2-KO and SIGN-R1-KO mice (Fig. 6d ). To study how the absence of IDCs, NK cells or SIGN-R1 affected the progression of influenza infection, we measured viral titres in tracheas from CCR2-KO and SIGN-R1-KO mice and in mice treated with NK1.1-depleting antibody at 3 d.p.i. We observed an increase in the influenza titres in all of the examined groups relative to the WT control ( Fig. 6e ). These results correlated with increased mortality (Fig. 6f ) and weight loss ( Fig. 6g ) in all of the deficient groups. Finally, we analysed the levels of influenza-specific antibodies in WT and SIGN-R1-KO mice at 5 and 10 d.p.i. ( Supplementary Fig. 6b ) with a sublethal dose of influenza virus. The results show that at 5 d.p.i., the mice had very low or undetectable titres of influenza-specific antibodies and that SIGN-R1-KO mice showed no deficiency in antibody production at later time points after infection.
Discussion
In this study, we aimed to elucidate the mechanism by which IDCs contribute to the control of influenza infection. Initially, we characterized the origin of the recruited IDCs. Previous studies had confirmed Ly6C high CCR2 + monocytes as the precursors of IDCs at the site of infection 16 . Here we observed that following their recruitment to the trachea, monocytes differentiated to IDCs and exhibited high expression of MHCII and CD11c and downregulation of CCR2. The prominent expression of CCR2 in IDC progenitors suggested a critical role for its ligands, CCL2 and CCL7, in the regulation of their migration to the inflamed tissue 23, 24 . The observed increase in the expression of CCL2 described in this study is probably associated with the recruitment of monocytes from the bone marrow to the bloodstream 25 and facilitates monocyte trafficking across an epithelial cell monolayer 26 . Previous studies demonstrated that type I IFN signalling is necessary for the enhancement and maintenance of CCL2 levels 27 . Accordingly, we observed an early and pronounced expression of type I IFN in the trachea following influenza infection. Moreover, we showed that this signalling pathway was necessary for CCL2 production in the trachea, as IFNAR-KO mice exhibited a severe reduction in the levels of this chemokine. This result correlated with a complete inhibition of the recruitment of CCR2 + monocytes and IDCs in the infected trachea. A similar effect on CCL2 production was previously reported in the draining LN of IFNAR-KO mice after vaccination with a non-replicative ultraviolet (UV)-inactivated PR8 28 . However, we cannot discount the possible effect that lack of viral control in IFNAR-KO mice 29 might have on the production of CCL2 and cell recruitment in the infected trachea.
Furthermore, we demonstrated that, following their recruitment in the trachea, IDCs are positioned in close proximity to the epithelial cell layer, which suggests a role of IDCs in sensing viral particles generated by infected epithelial cells. Moreover, it has been shown that IDCs from lungs have the capacity to internalize viral particles during influenza infection 30 . Therefore, we might expect a similar function of IDCs capturing influenza virus in the trachea.
C-type lectin receptors have recently emerged as inducers of the expression of specific genes in response to pathogens 31 . In our investigation, we studied the expression of the C-type lectin receptor SIGN-R1 in IDCs in the trachea. Our data showed that SIGN-R1 participates in the recognition of influenza virus, as blocking of this receptor affected the capture of PR8 by IDCs. We confirmed this hypothesis using SPR and demonstrated that SIGN-R1 binding to HA is glycosylation-dependent. Moreover, SIGN-R1 was able to recognize another surface protein of influenza virus, neuraminidase, and other viruses with a comparable glycosylation pattern. These results relate to the capacity of SIGN-R1 to bind the mannose present on HA from all influenza virus subtypes. Thus, we demonstrated that SIGN-R1 is a key receptor that is able to bind a number of viral glycoproteins by targeting the carbohydrate moiety. This property could be used for the development of therapeutic agents that could block the infection of a wide range of influenza virus subtypes. In addition, it has been previously demonstrated that SIGN-R1 recognizes other airborne pathogens such as Streptococcus pneumoniae 11 or Mycobacterium tuberculosis 32 , suggesting its potential therapeutic use for controlling airborne bacterial infections.
We also demonstrated that SIGN-R1 binding to influenza virus is necessary for the secretion of inflammatory cytokines, as expression in IDCs enhanced the production of CCL5, CXCL9 and CXCL10. Furthermore, we observed that CCL5 expression was not increased in SIGN-R1-KO IDCs when they were stimulated in vitro with HA. However, we did not observe significant production of CXCL9 and CXCL10. This might be related to the technical limitations of the in vitro model, in which IDCs do not receive additional activation signals (such as IFN-γ) that are required for the expression of these two chemokines 33 . CCL5, CXCL9 and CXCL10 are involved in the recruitment of T cells and NK cells to the site of infection 34, 35 . In the present study, we concluded that the reduction in the number of NK cells observed in SIGN-R1-KO mice was due to the reduced expression of these cytokines as a result of the lack of activation of tracheal IDCs. However, due to limitations in the in vivo model of infection-such as the absence of a mutant influenza virus lacking glycosylation-we cannot rule out that an alternative mechanism, independent of SIGN-R1 binding to viral proteins, might be responsible for the observed phenotype. The importance of NK cells during viral infection has been previously demonstrated in humans 36 and in mice, where the absence of NK cells was associated with a higher susceptibility to influenza virus 37 . In this study, we postulate that newly recruited NK cells perform effector functions intended to control the spread of the virus. In support of this hypothesis, we detected a robust expression in the recruited NK cells of the cytotoxic receptors NKG2D and NKp46, which are involved in the recognition of virus-associated molecules and the activation of these cells 38 .
Furthermore, in CCR2-KO and SIGN-R1-KO mice we observed a reduced infiltration of NK cells expressing IFN-γ, granzyme B and perforin. These molecules are critical for the effector function of NK cells [39] [40] [41] [42] . However, we also detected a decrease in the expression levels of CD69, granzyme B, CD11b and IFN-γ, which indicates that SIGN-R1 + IDCs contribute to the activation of NK cells during influenza infection. Previous studies have demonstrated that IL-18 plays an important role in NK cell activation 43 and IDCs have the capacity to produce IL-18 44 . Here we observed reduced levels of IL-18 in infected SIGN-R1-KO and CCR2-KO mice. Therefore, we believe that IDCs secrete IL-18, which promotes the activation and effector function of NK cells during influenza infection.
The increase in the viral titres observed in CCR2-KO and SIGN-R1-KO mice might be associated with a deficiency in the activation and recruitment of NK cells in these mouse models. These data support the role of IDCs in controlling the initial replication of the virus, as suggested by previous studies with influenza-infected CCR2-KO mice 45 . Interestingly, CCR2-KO mice exhibited increased viral levels and increased mortality after infection compared with SIGN-R1-KO mice, which coincided with reduced chemokine 9, 8, 9, 9, 9 and 8 ; CCR2-KO, n = 5, 3, 3, 5, 5, 5 and 5; SIGN-R1-KO, n = 9, 9, 9, 9, 9, 9 and production and NK-cell activation. This could be related to the severe reduction in IDC numbers in this strain rather than a deficiency in other cell subtypes or immune mechanisms. IDCs are known to also produce other cytokines, such as TNF and nitric oxide 8 , which limit influenza virus infection 46, 47 . Conversely, other reports have observed a lower susceptibility of CCR2-KO mice compared with WT animals after infection with influenza virus 48, 49 . This discrepancy has been proposed to be related to the differences in the experimental conditions, such as the concentration of the virus used for the initial infection 50 .
In conclusion, we demonstrated that IDCs have an important role in the initial events of the immune response against influenza infection through the direct recognition of viral particles by SIGN-R1 and the secretion of chemokines that recruit and activate NK cells in the tracheal mucosa. Consequently, NK cells contribute to the early elimination of virus-infected cells in the trachea ( Supplementary Fig. 6c ).
Methods
Mice. C57BL/6 mice were bred in-house or acquired from Janvier Labs. SIGN-R1-KO 32 mice were donated by O. Neyrolles (Institut de Pharmacologie et de Biologie Structurale, Toulouse, France). The following transgenic strains with a C56BL/6 background were used: CD11c-YFP 51 , CCR2-KO 52 and IFNAR-KO 53 . Mice were maintained in specific pathogen-free facilities at the Institute for Research in Biomedicine, Bellinzona. Experiments were performed in accordance with the Swiss Federal Veterinary Office guidelines and animal protocols were approved by the local veterinary authorities.
Antibodies. The fluorescently labelled antibodies for cell-surface phenotypic staining, cell sorting and intracellular staining are listed in Supplementary  Table 1 . The following depletion antibodies were used: for NK cells, NK1.1 (PK136, BioXcell) and mouse IgG2a (C1.18.4, BioXcell) as isotype control. The following antibodies were used for ELISA: FI6 (HUMABS BioMed); alkaline phosphatase AffiniPure goat anti-human IgG, Fcγ-fragment specific (Jackson Immunoresearch); human anti-F (RSV) IgG1 (MPE8, HUMABS BioMed) as isotype control; and alkaline-phosphate-conjugated goat anti-mouse total IgG, IgG1, IgG2a, IgG2b, IgG3, IgM and IgA antibodies (Southern Biotec). For the SPR assays, monoclonal antibody H36-7 17 was used as positive control.
Virus production, generation of recombinant influenza virus, infection and survival assay.
The influenza virus strain A/PR/8/34 was grown, purified, inactivated and labelled as described previously 12 . To generate the recombinant influenza virus PR8 carrying an mCherry reporter (rPR8-NS1-mCherry), a plasmid encoding the NS1 of PR8 fused with mCherry gene was constructed by overlapping fusion PCR. In brief, the NS1 open reading frame without the stop codon was fused to the N terminus of mCherry via a GSGRRQAGGT linker region (NS1-mCherry). mCherry was followed by a short GSGSG linker, a 19-amino acid 2A autoproteolytic site (ATNFSLLKQAGDVEENPGP) derived from porcine teschovirus-1 and by the nuclear export protein open reading frame. The first 147 nucleotides of the nuclear export protein were silently mutated. Silent mutations were also introduced into the endogenous splice-acceptor site in the NS1 open reading frame to prevent splicing. The rPR8-NS1-mCherry virus was rescued using standard reverse-genetics techniques. Age-matched (6-8 week old) female mice were anaesthetised with a mix of ketamine (100 mg per kg (body weight), Parke Davis) and xylazine (10 mg per kg (body weight), Bayer) and intranasally inoculated with 40 µl (20 µl in each nostril) containing 200 p.f.u. of influenza virus. In survival studies, mice were monitored daily for up to 12 d and sacrificed when weight loss was more than 20%. For NK-cell depletion, 200 µg of the depletion antibody NK1.1 (see ' Antibodies') was administered intraperitoneally 2 d before infection and 1 d.p.i. For analysis of influenza-specific antibodies, mice were infected with 70 p.f.u. of influenza virus. The human RSV virus (A2 strain) was obtained from ViraTree and propagated and expanded in human epithelial type 2 (HEp-2) cells. The MPV virus (strain A1/6621/01) was propagated and expanded in rhesus monkey kidney epithelial (LLC-MK2) cells.
Flow cytometry. Tracheas were collected from the larynx to the tracheal bifurcation, mechanically disrupted with scissors and digested for 45 min at 37 °C in an enzyme mix composed of DNase I (0.28 mg ml −1 , Amresco) and 0.26 U ml −1 Liberase TL Research Grade (Roche) in RPMI 1640 Medium (Gibco) followed by a stop solution of 2 mM EDTA (Sigma-Aldrich) and 2% heat-inactivated filter-sterilized Fetal Calf Serum (Thermo Fisher Scientific) in PBS (Sigma-Aldrich). Single-cell populations were obtained by forcing the remaining tissue pieces through a 40 µm strainer followed by lysis of red blood cells. Fc receptors from the isolated cells were blocked (CD16/32, Biolegend) followed by surface staining and analysis by flow cytometry on a LSRFortessa (BD Biosciences).
Where indicated, intracellular staining was performed using Intracellular Fixation and Permeabilization Buffer Set (eBioscience) following the manufacturer's instructions. Dead cells were excluded using Zombie Aqua fixable viability dye (Biolegend) and data were analysed using FlowJo software (TriStar Inc.; v10.1).
SIGN-R1 blocking assays.
Tracheas were processed as for flow cytometric analysis and tracheal IDCs in single-cell suspensions were sorted using a FACSAria IIIu (BD Biosciences) on the basis of their expression markers (CD45 + CD11c + MH CII + CD11b + Ly6C high ). IDCs were dispensed into a round-bottom 96-well plate containing 5 × 10 4 cells in 100 µl of RPMI 1640 Medium (Gibco) per plate and cultured for 2 h at 37 °C. Following this, cell suspensions were incubated with 1 µg of fluorescently labelled SIGN-R1-blocking antibody or isotype control antibody for 30 min on ice (see ' Antibodies'). After washing, cell suspensions were (except for negative control wells) incubated with 5 × 10 5 p.f.u. of DiO-labelled UVinactivated PR8 for 1 h on ice. Finally, after washing, IDC suspensions were surface stained using 1 µg of fluorescently labelled SIGN-R1-blocking antibody, fixed and analysed by flow cytometric analysis.
Immunohistology of tracheal explants. Immunofluorescence confocal microscopy was performed using a Leica TCS SP5 confocal microscope using sequential acquisition to limit the signal crosstalk. For immunofluorescence images shown in Figs. 2 and 5 and Supplementary Figs. 1 and 2 , tracheas were collected and fixed in 4% paraformaldehyde at 4 °C for 1 h. Then, in cases where the epithelial cell layer was stained, a solution containing 10 µM of CellTracker Orange ((5-(and-6)-(((4-chloromethyl)benzoyl) amino)tetramethylrhodamine)) (CMTMR) (Thermo Fisher Scientific) or 5 µM Cell Trace Violet (Thermo Fisher Scientific) was placed in the intraluminal space of the trachea and explants were incubated for 30 min at 7 °C and washed three times with PBS. Next, they were blocked with sera from the same host that the indicated antibodies used for staining. The antibodies used for staining were diluted in 0.01% Triton + 1% BSA in PBS and incubated with the tracheal explans for 4 h at 4 °C with shaking (see ' Antibodies'). Tracheas were cut into two halves along the long axis. Pieces were placed on a microscopy slide and embedded in Fluoromount Aqueous Mounting Medium (Sigma-Aldrich). Three-dimensional images were acquired using a HCX PL APO CS ×20 0.7 numerical aperture oil-immersion objective (z step was 1 μm for a total depth ranging from 50 μm to 112 μm). The cell populations were identified by assessing the signal intensity in the different channels as described below (or explained in the caption for Fig. 2 and Supplementary Fig. 2 ). In Fig.  5k , IDCs were defined as CD11c + Ly6C + NK1.1 − and NK cells were defined as CD11c − NK1.1 + . The basement membrane was identified (in the absence of additional specific staining) by manually localizing the position of collagen fibres that generated autofluorescence signals detectable in the 412-464 nm channel after excitation with a 405 nm laser during the imaging process. For every reconstruction, 10-40 cells of each cell type were analysed. Three-dimensional surfaces shown in Figs. 2, 5 and Supplementary Fig. 2 were reconstructed using Imaris software (Bitplane; v8.4.2). Counting and localization with respect to the collagen layer of basement membrane (Figs. 2d and 5k and Supplementary Fig. 2b ) was performed manually using the cell counter plugin in FIJI software (v1.48k) 54 . In Supplementary Fig. 6a , the average distance between NK cells and their nearest neighbour cells in the IDC population was calculated measuring the Euclidean distance between the centres of the identified cells. In Supplementary Fig. 6b , contact between cells was calculated as described 55 and was considered when their distance (closest voxels) was less than or equal to 5 µm. SINGR1-PR8 colocalization. In Fig. 4 , IDCs were isolated from tracheas as mentioned in the previous section and cultured in RPMI 1640 medium in μ-Slide 8 well ibiTreat (ibidi) for 3 h at 37 °C to allow them to attach to the bottom of the slide wells. Cell suspensions were subsequently incubated with 5 × 10 5 p.f.u. of PR8-DiO for 1 h on ice. After washing, IDC suspensions were surface stained using 1 µg of fluorescently labelled SIGN-R1 antibody. Finally, cells were fixed, embedded with Vectashield mounting medium with DAPI (Vector Laboratories) and examined by immunofluorescence confocal microscopy. Three-dimensional images were acquired using a HCX PL APO Lambda Blue ×63.0 1.40 numerical aperture oil-immersion objective (z step was 1 μm for a total depth 20 μm). Threedimensional surfaces shown in Fig. 4 were reconstructed using Imaris software (Bitplane; v8.4.2). 
Recombinant proteins and enzymatic treatment. Recombinant mouse SIGN-R1-
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Fisher Scientific, clone 4E3D10H2/E3) in 1% BSA for 2 h and secondary goat antimouse IgG (H+L)-HRP conjugated (Thermo Fisher Scientific). SIGN-R1 ELISA. Maxisorp (Nunc) ELISA plates were coated with 50 μl of UVinactivated virus (1 mg ml −1 of PR8, RSV or MPV), recombinant HA (2 µg ml −1 ) or N1 (2 µg ml −1 ) at 4 °C overnight. The plates were washed with PBS, blocked with 1% BSA in PBS for 1 h at room temperature and incubated with dilutions of recombinant mouse SIGN-R1-Fc chimaera protein (SIGN-R1-Fc, R&D systems). For plates coated with N1, Fl6 antibody and the isotype control human anti-F (RSV) IgG1 (see ' Antibodies') were added to the wells. After incubation for 1 h at room temperature, plates were washed and 50 μl of alkaline phosphatase AffiniPure goat anti-human IgG, Fcγ-fragment specific (see ' Antibodies') diluted 1:1,000 in 1% BSA in PBS was added to each well. After 1 h incubation at room temperature and washing, 50 μl of 1.0 mg ml −1 para-nitrophenylphosophate in 0.2M Tris buffer (prepared with SIGMAFAST para-nitrophenyl phosphate tablets (Sigma-Aldrich) in deionized water was added to each well, followed by incubation at room temperature for 45 min. Absorbance was read on a Biotel PoweWave 340 (Biotek) microplate reader at 405 nm. EC 50 values were inferred from fitting binding curves using GraphPad Prism 7 software.
Influenza-specific serum antibody ELISA. After infection, blood was collected at 5 and 10 d.p.i. and serum was obtained. ELISAs were performed as previously described 56 . Absorbance was read on a Biotel PoweWave 340 (Biotek) microplate reader at 405 nm.
Tracheal cytoplex assay. LEGENDPlex assays (Mouse Proinflammatory
Chemokine Panel and Mouse Inflammation Panel; Biolegend) were performed to monitor cytokine and chemokine expression. In brief, tracheas were collected and the luminal side was washed five times with 100 µl of ice-cold PBS. Tracheal washes were centrifuged at 1,500 r.p.m. for 5 min and the supernatant was collected. Supernatants (25 μl aliquots) were processed following the manufacturer's instructions. Samples were analysed by flow cytometry on LSRFortessa (BD Biosciences) and data were analysed using LEGENDPlex software (Biolegend; v7.0).
Generation of IDCs and in vitro culture with influenza HA. IDCs were generated by intranasal administration of 40 µg of polyinosinic:polycytidylic acid to mimic the replication intermediates present in cells infected with RNA viruses in the lungs 57 . After 2 d of administration, lungs were collected, IDCs were sorted as described in Flow cytometry and SIGN-R1 blocking assays, and 5 × 10 4 cells were plated per well into a round-bottom 96-well plate in 65 µl complete RPMI medium alone or RPMI + Inflexal V (60 µl of medium + 5 µl of vaccine solution) medium. After 12 h, 25 µl of supernatant was used to perform Mouse Proinflammatory Chemokine Panel LEGENDPlex assay.
PCR with reverse transcription. For cytokine expression in whole tissue, trachea were collected at the specified time after infection in 700 µl of TRIzol reagent (Thermo Fisher Scientific), disrupted in lysing matrix D 1.4 mm ceramic sphere tubes using FastPrep-24 tissue disruption (MP Biomedicals) and RNA was isolated using a RNAeasy Mini kit (Qiagen). For analysis of cytokine expression of IDCs and epithelial cells, tracheas were collected at 0 and 3 d.p.i., single-cell suspensions were obtained, and IDCs (CD45 + CD11c + MHCII + CD11b + Ly6C high ) and epithelial cells (CD45 − EpCam + ) were sorted as described above, and RNA was isolated using a RNAeasy Mini kit (Qiagen). Due to the absence of IDCs at 0 d.p.i., RNA was extracted from uninfected tracheal DCs (CD45 + CD11c + MHCII + ). After RNA isolation, 0.5-1 μg of cDNA was synthesized using a cDNA synthesis kit (Applied Biosystems) following the manufacturer's recommendations. For the PCR reaction, SYBR Master Mix (Applied Biosystems) was used and samples were run on a 7900HT Fast Real-Time PCR System (Applied Biosystems). To measure expression levels of the cytokines IFN-α, IFN-β, CCL2, IL-18, CCL5, CXCL9 and CXCL10, the sets of primers listed in Supplementary Table 2 were used. The Pfaffl method 58 was used to calculate the relative expression of the transcripts. Viral titres. Influenza titres from trachea homogenates were measured using a TCID 50 assay. In brief, tracheas were aseptically removed from mice, weighed and disrupted in 1 ml of ice-cold sterile PBS. The determination of TCID 50 was carried out using 96-well plates containing confluent Madine-Darby canine kidney (MDCK) cell monolayers. The MDCK cells were incubated with serial threefold dilutions of influenza virus culture supernatant in infection medium (Minimum Essential Medium Eagle+ GlutaMAX-I (Gibco) with antibiotics and 1 µg ml −1 of TPCK-Treated Trypsin (Sigma-Aldrich) without FCS) at 37 °C. After 1 h, the monolayer was rinsed with PBS, overlaid with infection medium and incubated at 37 °C for 4 d. To identify influenza virus-positive wells, the monolayers where stained with crystal violet (Sigma-Aldrich) in 70% methanol. Titres were expressed as the dilution of tracheal extract at which 50% of the MDCK cultures revealed virus growth, as calculated by the Spearman and Karber method.
SPR.
The experiments were carried out at 25 °C on a ProteON XPR-36 instrument (Bio-Rad Laboratories) in PBS (GIBCO, Thermo Fisher Scientific) and 0.05% Tween-20 (Sigma). The indicated proteins were immobilized on a ProteON GLM sensor chip (Bio-Rad Laboratories) surface through amine coupling at 100 nM and a blank surface with no protein was created under identical coupling conditions for use as a reference. Analyte proteins (HA with different glycosylation patterns), were injected at a flow rate of 100 μl min −1 , at concentrations of 100, 75, 50, 25 and 12.5 nM in different sensor channels. The data were processed using Proteon Manager software (v3.1) and double-referenced by subtraction of the blank surface and buffer-only injection. k a , k d and K D were calculated by two-state fitting.
Statistics. Prism 7 (GraphPad) was used for statistical analyses and data presentation. Group comparisons were assessed using the unpaired two-tailed Student's t-test. For statistical analysis between survival curves the Mantel-Cox method was used. Last updated by author(s): May 31, 2019 Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form provides structure for consistency and transparency in reporting. For further information on Nature Research policies, see Authors & Referees and the Editorial Policy Checklist.
Statistics
For all statistical analyses, confirm that the following items are present in the figure legend, table legend, main text, or Methods section.
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Our web collection on statistics for biologists contains articles on many of the points above.
Software and code
Policy information about availability of computer code Data collection
Mycoplasma contamination
All cell lines were tested negative for mycoplasma contamination using MycoAlert ® Mycoplasma detection kit (Lonza, LT07-118).
Commonly misidentified lines (See ICLAC register)
No commonly misidentified cell lines were used in this study.
Animals and other organisms
Policy information about studies involving animals; ARRIVE guidelines recommended for reporting animal research Laboratory animals C57BL/6 mice were bred in-house or acquired from Janvier labs. SIGNR1-KO, mice were kindly donated by Dr. Olivier Neyrolles. The following transgenic strains with a C57BL/6 background were used: CD11c-YFP, CCR2-KO, IFNAR-KO. Mice were maintained in specific pathogen-free facilities at the Institute for Research in Biomedicine, Bellinzona. Experiments were performed in accordance with the Swiss Federal Veterinary Office guidelines and animal protocols were approved by the local veterinarian authorities. For experiments, female mice of 6-8 weeks old were used.
Wild animals
This study did not involve wild animals.
Field-collected samples
No samples collected from the field.
Ethics oversight
Experiments were performed in accordance with the Swiss Federal Veterinary Office guidelines and animal protocols were approved by the local veterinarian authorities.
Note that full information on the approval of the study protocol must also be provided in the manuscript.
Flow Cytometry Plots
Confirm that:
The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
A numerical value for number of cells or percentage (with statistics) is provided.
Methodology Sample preparation
Trachea was collected from the larynx to the tracheal bifurcation, mechanically disrupted with scissors and digested for 45 min at 37°C in an enzyme mix composed of: DNase I (0.28 mg/ml, Amresco), and 0.26 units / ml of Liberase TL Research Grade (Roche) in RPMI 1640 Medium (Gibco) followed by a stop solution of 2 mM EDTA (Sigma Aldrich) and 2 % heat-inactivated filtersterilised Fetal Calf Serum (Thermo Fisher Scientific) in PBS (Sigma Aldrich). Single cell populations were obtained by forcing the remaining tissue pieces through a 40-μm strainer followed by lysis of red blood cells.
Instrument
LSRFortessa™ (BD Biosciences) was used for data collection.
Software
FACSDiva™ software (BD Biosciences, version 6.2) was used to collect the flow cytometry data. FlowJo software (TriStar Inc., version 10.1 ) was used to analyse flow cytometry data. LEGENDPlex™ software (Biolegend, version 7.0) was used to analyse data from Cytoplex assays.
